Amos de Jong

Researcher/Postdoc

Biography

Amos de Jong obtained his PhD in Drug Innovation from the Utrecht University in 2024. Amos’ PhD thesis focuses on the regulatory aspects of decentralized clinical trials and encompasses both qualitative and quantitative research methods. He works as a Postdoc at the Julius Center (Epidemiology of Infectious Diseases) of the University Medical Center Utrecht. In this Postdoc position, his research will focus on the regulatory aspects of (operational and methodological) clinical trial innovation, focusing on adaptive platform trials.

Contact

ajong45@umcutrecht.nl

Pure profile

Recent publications

All publications

Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on Decentralization Helga Gardarsdottir, Hamidou Traore, Kate Huntley, Dinesh Mistry, Amos J de Jong, Agnes Legathe, Tim de Smedt, Scott Askin, Megan Heath, Solange Corriol-Rohou, Bart Lagerwaard, Mira G P Zuidgeest,
Clinical Pharmacology and Therapeutics, 2025, vol. 118, p.1046-1056

The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants-Insights from the Trials@Home RADIAL Proof-of-Concept Trial Megan Heath, Amos J de Jong, Shaun Magorrian-Spence, Chao Jin, Danny R van Weelij, Lucas Pagnier, Yvonne van Rijswick, Volker Haufe, Bart Lagerwaard, Mira G P Zuidgeest,
Clinical Pharmacology and Therapeutics, 2025, vol. 118, p.1079-1089

The impact of operational trial approaches on representativeness Amos J. de Jong, Mira G.P. Zuidgeest, Yared Santa-Ana-Tellez, Christine E. Hallgreen, Thomas T. van Sloten, Anthonius de Boer, Helga Gardarsdottir,
Drug Discovery Today, 2025, vol. 30

Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials Regulation Amos J de Jong, Helga Gardarsdottir, Yared Santa-Ana-Tellez, Anthonius de Boer, Mira Gp Zuidgeest
Clinical Trials, 2025, vol. 22, p.494-500

Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines Christine C van Hattem, Amos J de Jong, Jolien S de Groot, Jarno Hoekman, K Esther Broekman, Gabe S Sonke, Paula B van Hennik, Lourens T Bloem
BMJ Open, 2024, vol. 14

Regulatory readiness to facilitate the appropriate use of innovation in clinical trials Amos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, Anthonius de Boer, Helga Gardarsdottir,
Drug Discovery Today, 2024, vol. 29

External positions

Editor in Training for Clinical Pharmacology & Therapeutics - manuscript review and decision making; assist with strategic planning; assist social media strategy - American Society for Clinical Pharmacology & Therapeutics